Similar articles

• Hepatocarcinogenesis: a dynamic cellular perspective.

  Farber E, Sarma DS. Farber E, et al. Lab Invest. 1987 Jan;56(1):4-22. Lab Invest. 1987. PMID: 3025514 Review. No abstract available.
• Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression.

  Grasl-Kraupp B, Ruttkay-Nedecky B, Müllauer L, Taper H, Huber W, Bursch W, Schulte-Hermann R. Grasl-Kraupp B, et al. Hepatology. 1997 Apr;25(4):906-12. doi: 10.1002/hep.510250420. Hepatology. 1997. PMID: 9096596
• Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats.

  Hard GC, Iatropoulos MJ, Jordan K, Radi L, Kaltenberg OP, Imondi AR, Williams GM. Hard GC, et al. Cancer Res. 1993 Oct 1;53(19):4534-41. Cancer Res. 1993. PMID: 8402624
• Liver tumour promotion by phenobarbital: comparison of rat and human studies.

  McLean AE, Driver HE, Sutherland IA. McLean AE, et al. Prog Clin Biol Res. 1992;374:251-9. Prog Clin Biol Res. 1992. PMID: 1320274 Review. No abstract available.
• The relevance of peroxisome proliferation and cell proliferation in peroxisome proliferator-induced hepatocarcinogenesis.

  Rao MS, Reddy JK. Rao MS, et al. Drug Metab Rev. 1989;21(1):103-10. doi: 10.3109/03602538909029957. Drug Metab Rev. 1989. PMID: 2696631 Review. No abstract available.